Managing Osteoarthritis
Osteoarthritis, a condition affecting nearly 7% of the global population, is caused by gradual wear and tear of joint cartilage. Monovisc, a viscosupplement, is an effective non-surgical treatment that improves joint lubrication and reduces pain. It has reportedly transformed lives like that of a firefighter named John, helping him regain mobility. The dosage of Monovisc is determined based on factors such as patient’s age and severity of the condition, and accurate dosage is crucial for successful treatment. Studies have shown positive results, making Monovisc a promising option for osteoarthritis management.